Skip to main content
IMS Events Main banner
    22nd International Myeloma Society Annual Meeting
    Industry Symposium

    Industry Symposium Supported by AbbVie: Infection Risk with T-Cell Engagers in Multiple Myeloma

    Thursday, September 18, 2025
    17:00 - 18:00 East Coast USA Time
    Location: Hall FG

      Chair(s)

    • Ajai Chari, MD

      Director of Multiple Myeloma Program Professor of Clinical Medicine
      University of California, San Francisco
      San Francisco, California

    Presentations:

    • 17:00 - 17:03 East Coast USA Time
      Welcome and Introductions

      Speaker: Ajai Chari, MD – University of California, San Francisco

    • 17:03 - 17:18 East Coast USA Time
      Factors Influencing Infection Risk in MM

      Speaker: Guido Lancman, MD, M.Sc. – University of Toronto, Princess Margaret Cancer Centre

    • 17:18 - 17:28 East Coast USA Time
      Infection Risks with T-Cell Engaging Therapies

      Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

    • 17:33 - 17:45 East Coast USA Time
      Strategies for Mitigating Infection Risk

      Speaker: Ajai Chari, MD – University of California, San Francisco

    • 17:45 - 18:00 East Coast USA Time
      Panel Discussion